Cronos Group Inc. Common Share (CRON) is a publicly traded Healthcare sector company. As of September 11, 2026, CRON trades at $3.15 with a market cap of $1.16B and a P/E ratio of 15.63. CRON moved -0.95% today. Year to date, CRON is +17.04%; over the trailing twelve months it is +24.90%. Its 52-week range spans $1.60 to $3.61. Analyst consensus is buy with an average price target of $3.41. Rallies surfaces CRON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CRON insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.15 |
| Market Cap | $1.16B |
| P/E Ratio | 15.63 |
| EPS | $0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.61 |
| 52-Week Low | $1.60 |
| Volume | 697.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $179.09M |
| Net Income | $79.20M |
| Gross Margin | 45.86% |
2 analysts cover CRON: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.41.